Nova Patents
AT283372T

Angiotensinogen gene variants and predisposition to hypertension

Abstract

(57) The relevance of the molecular variant of a summary アンジオテンシノーゲン gene and human high blood pressure is indicated. By this relevance, screening of high blood pressure and those that have the genius of essential hypertension and pregnancy induced hypertension (子かん前症) especially is attained.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

27 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
95244292United States of AmericaA
9309136United States of AmericaW

Members27

Family members, oldest first
DocumentOfficeKind
CA2145415A1CanadaA1
WO9408048A1World Intellectual Property Organization (WIPO)A1
AU5725094AAustraliaA
US5374525AUnited States of AmericaA
EP0665898A1European Patent Office (EPO)A1
KR950704507ARepublic of KoreaA
NZ259092ANew ZealandA
JPH08505043AJapanA
AU670990B2AustraliaB2
US5589584AUnited States of AmericaA
US5763168AUnited States of AmericaA
EP0665898A4European Patent Office (EPO)A4
US5998145AUnited States of AmericaA
CA2331331A1CanadaA1
WO0000647A1World Intellectual Property Organization (WIPO)A1
AU3645999AAustraliaA
US6153386AUnited States of AmericaA
US6165727AUnited States of AmericaA
EP1092042A1European Patent Office (EPO)A1
JP3159708B2JapanB2
EP1092042A4European Patent Office (EPO)A4
JP2002519012AJapanA
AU754923B2AustraliaB2
EP0665898B1European Patent Office (EPO)B1
AT283372TThis recordAustriaT
ATE283372T1AustriaT1
DE69333710D1GermanyD1